Dublin, March 30, 2016 -- Research and Markets has announced the addition of the "Structural Heart Devices Global Market - Forecast to 2022" report to their offering.
The cardiovascular diseases which also include structural heart diseases have become leading cause of death. It is projected that, with newfound prosperity due to globalization and industrialization has led to changing lifestyle increasing risk of younger people developing cardiovascular diseases.
Structural heart devices has emerged as a new focus area of medical device manufacturers as the population of most developed and developing countries continue to become older and risk of cardiovascular diseases increase with aging.
The increased interest has led to development of new technologies and devices that are less invasive and address the need of treatment of patients who are considered too weak to withstand the trauma of an open heart surgery.
The structural heart device market is classified based on type, end-users and geography. The structural heart device market by type is segmented into repair and replacement markets base on the type of procedure performed. The repair segment is further sub segmented into annuloplasty, valvuloplasty and Transcatheter mitral valve repair (TMVR).
The replacement segment is further segmented by technique into surgical valves and Transcatheter aortic valves replacement (TAVR). The surgical valve is sub-segmented as mechanical and tissue heart valves.
The structural heart devices end-user market is segmented into public and private hospitals based on location where the procedures are performed.
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunties
3.3.1.1 Prevalence Of Heart Valve Disorders Due To Aging Population
3.3.1.2 Technology Advancements And Growing Healthcare Budgetary Allocation
3.3.1.3 Demand For Minimally Invasive Surgery
3.3.2 Restraints And Threats
3.3.2.1 Strict Regulatory Requirements With High Cost Of Development
3.3.2.2 Lack Of Patient Awareness And Healthcare Infrastructure In Developing Countries
3.3.2.3 High Cost Of Devices And Procedure
3.3.3 Burning Issue
3.3.3.1 Lack Of Trained Professionals
3.4 Regulatory Affairs
3.5 Reimbursement Scenario
3.6 Cpt Codes
3.7 Patent Trends
3.8 Technological Advancements
3.8.1 Tissue Engineering
3.8.2 Polymeric Heart Valves
3.8.3 Sutureless Aortic Valve Replacement (Su-Avr) System
3.8.4 Cardiac Or Ventricular Remodeling
3.8.5 Endoscopic Aortic Valve Replacement (Teavr) System
3.8.6 3-D Printed Model
3.9 Upcoming Technologies
3.10 Clinical Trials
3.11 Porter'S Five Force Analysis
3.11.1 Threat Of New Entrants
3.11.2 Threat Of Substitutes
3.11.3 Bargaining Power Of Suppliers
3.11.4 Bargaining Power Of Buyers
3.11.5 Rivalry Among Existing Competitors
3.12 Market Share Analysis By Major Players
4 Structural Heart Devices Global Market, By Type
4.1 Introduction
4.2 Structural Heart Repair Devices
4.2.1 Annuloplasty
4.2.2 Valvuloplasty
4.2.3 Transcatheter Mitral Valve Repair (Tmvr)
4.3 Structural Heart Replacement Valves
4.3.1 Introduction
4.3.2 Surgical Heart Valve Replacement
4.3.2.1 Mechanical Replacement Heart Valves
4.3.2.2 Biological Replacement Heart Valves (Tissue Valves)
4.3.3 Transcatheter Aortic Valve Replacement(Tavr)
4.3.4 Transcatheter Mitral Valve Replacement (Tmvr)**
5 Structural Heart Devices Global Market, By End-Users
5.1 Introduction
5.2 Public Hospitals
5.3 Private Hospitals
6 Regional Analysis
7 Company Developments
7.1 Introduction
7.2 Approvals
7.3 Mergers & Acquisitions
7.4 New Product Launches
7.5 Agreements & Colloborations
8 Major Companies
8.1 Abbott Laboratories
8.2 Boston Scientific Corpoartion
8.3 Braile Biomedica
8.4 Cryolife, Inc.
8.5 Edwards Lifesciences Corp.
8.6 Jenavalve Technology
8.7 Lepu Medical Technology(Beijing) Co., Ltd.
8.8 Livanova Plc (Sorin Group)
8.9 Medtronic, Plc
8.10 St. Jude Medical, Inc.
Companies Mentioned
- Abbott Laboratories U.S.
- Abiomed Inc. U.S.
- Balton Sp. z o.o. Poland
- Bard Peripheral Vascular, Inc U.S
- BioVentrix, Inc U.S.
- Boston Scientific Corporation U.S.
- Braile bio medica Brazil
- Cardiac Dimensions, Inc. U.S.
- Cardiokinetix Inc U.S.
- Cardiosolutions, Inc U.S.
- Cephea valve technologies U.S.
- Colibri Heart Valve, LLC U.S.
- Coramaze Technologies GmbH Germany
- Cryo life Inc. U.S.
- Direct Flow Medical, Inc U.S.
- Edwards lifesciences Corporation U.S.
- Guided Delivery Systems, Inc. U.S.
- Heart Leaflet Technologies, Inc. U.S.
- HighLife Medical U.S.
- InterValve, Inc U.S
- JenaValve Technology GmbH Germany
- Labcor Laboratórios Ltda. Brazil
- Leman Cardiovascular Switzerland
- Lepu Medical Technology China
- Lifenet Health, Inc. U.S.
- LivaNova PLC UK
- Medtentia International Ltd Oy Finland
- Medtronic PLC Ireland
- MiCardia Corporation U.S.
- Micro Interventional Devices, Inc. U.S.
- MitrAssist Ltd. Israel
- Mitralign, Inc. U.S.
- NaviGate Cardiac Structures Inc. U.S.
- Neovasc Inc Canada
- NuMED, Inc. U.S
- Occlutech Germany
- Osypka AG Germany
- Secant Medical, Inc. U.S.
- St.Jude Medical Corporation U.S.
- Symetis SA Switzerland
- TTKChitra HeartValve India
- The Phoenix Cardiac device Pvt. Ltd. India
- Thubrikar Aortic Valve, Inc. U.S.
- TransCardiac Therapeutics, LLC U.S.
- Transcatheter Technologies GmbH Germany
- Valcare Medical, Inc. Israel
- Valtech Cardio, Ltd Israel
- Venus Medtech (Hangzhou) Inc. China
- W. L. Gore and Associates, Inc. U.S.
- Xuzhou Yatai Scientific CO.,LTD
For more information visit http://www.researchandmarkets.com/research/rtr6j6/structural_heart
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices


Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 



